These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 36802270)

  • 1. Regulation of programmed death ligand 1 expression by interferon-γ and tumour necrosis factor-α in canine tumour cell lines.
    Owaki R; Deguchi T; Konnai S; Maekawa N; Okagawa T; Hosoya K; Kim S; Sunaga T; Okumura M
    Vet Comp Oncol; 2023 Jun; 21(2):279-290. PubMed ID: 36802270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nafamostat mesilate, a serine protease inhibitor, suppresses interferon-gamma-induced up-regulation of programmed cell death ligand 1 in human cancer cells.
    Homma S; Hayashi K; Yoshida K; Sagawa Y; Kamata Y; Ito M
    Int Immunopharmacol; 2018 Jan; 54():39-45. PubMed ID: 29100036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Escherichia coli K12 Upregulates Programmed Cell Death Ligand 1 (PD-L1) Expression in Gamma Interferon-Sensitized Intestinal Epithelial Cells via the NF-κB Pathway.
    Lee SA; Wang Y; Liu F; Riordan SM; Liu L; Zhang L
    Infect Immun; 2020 Dec; 89(1):. PubMed ID: 33046511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inflammatory cytokines IL-17 and TNF-α up-regulate PD-L1 expression in human prostate and colon cancer cells.
    Wang X; Yang L; Huang F; Zhang Q; Liu S; Ma L; You Z
    Immunol Lett; 2017 Apr; 184():7-14. PubMed ID: 28223102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-155 induction via TNF-α and IFN-γ suppresses expression of programmed death ligand-1 (PD-L1) in human primary cells.
    Yee D; Shah KM; Coles MC; Sharp TV; Lagos D
    J Biol Chem; 2017 Dec; 292(50):20683-20693. PubMed ID: 29066622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PD-L1 induced by IFN-γ from tumor-associated macrophages via the JAK/STAT3 and PI3K/AKT signaling pathways promoted progression of lung cancer.
    Zhang X; Zeng Y; Qu Q; Zhu J; Liu Z; Ning W; Zeng H; Zhang N; Du W; Chen C; Huang JA
    Int J Clin Oncol; 2017 Dec; 22(6):1026-1033. PubMed ID: 28748356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IRF-1 inhibits NF-κB activity, suppresses TRAF2 and cIAP1 and induces breast cancer cell specific growth inhibition.
    Armstrong MJ; Stang MT; Liu Y; Yan J; Pizzoferrato E; Yim JH
    Cancer Biol Ther; 2015; 16(7):1029-41. PubMed ID: 26011589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune regulation of canine tumour and macrophage PD-L1 expression.
    Hartley G; Faulhaber E; Caldwell A; Coy J; Kurihara J; Guth A; Regan D; Dow S
    Vet Comp Oncol; 2017 Jun; 15(2):534-549. PubMed ID: 26842912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term use of indomethacin leads to poor prognoses through promoting the expression of PD-1 and PD-L2 via TRIF/NF-κB pathway and JAK/STAT3 pathway to inhibit TNF-α and IFN-γ in hepatocellular carcinoma.
    Xu P; Sun Z; Wang Y; Miao C
    Exp Cell Res; 2015 Sep; 337(1):53-60. PubMed ID: 26162855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Macrophage migration inhibitory factor-CD74 interaction regulates the expression of programmed cell death ligand 1 in melanoma cells.
    Imaoka M; Tanese K; Masugi Y; Hayashi M; Sakamoto M
    Cancer Sci; 2019 Jul; 110(7):2273-2283. PubMed ID: 31069878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PD-L1 expression is mainly regulated by interferon gamma associated with JAK-STAT pathway in gastric cancer.
    Mimura K; Teh JL; Okayama H; Shiraishi K; Kua LF; Koh V; Smoot DT; Ashktorab H; Oike T; Suzuki Y; Fazreen Z; Asuncion BR; Shabbir A; Yong WP; So J; Soong R; Kono K
    Cancer Sci; 2018 Jan; 109(1):43-53. PubMed ID: 29034543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Met inhibition revokes IFNγ-induction of PD-1 ligands in MET-amplified tumours.
    Martin V; Chiriaco C; Modica C; Acquadro A; Cortese M; Galimi F; Perera T; Gammaitoni L; Aglietta M; Comoglio PM; Vigna E; Sangiolo D
    Br J Cancer; 2019 Mar; 120(5):527-536. PubMed ID: 30723303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interferon-gamma and tumor necrosis factor-alpha synergistically enhance the immunosuppressive capacity of human umbilical-cord-derived mesenchymal stem cells by increasing PD-L1 expression.
    Chen Z; Yao MW; Shen ZL; Li SD; Xing W; Guo W; Li Z; Wu XF; Ao LQ; Lu WY; Lian QZ; Xu X; Ao X
    World J Stem Cells; 2023 Aug; 15(8):787-806. PubMed ID: 37700823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Shikonin-mediated PD-L1 degradation suppresses immune evasion in pancreatic cancer by inhibiting NF-κB/STAT3 and NF-κB/CSN5 signaling pathways.
    Ruan Z; Liang M; Shang L; Lai M; Deng X; Su X
    Pancreatology; 2021 Apr; 21(3):630-641. PubMed ID: 33707115
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunosuppression of Human Adipose-Derived Stem Cells on T Cell Subsets via the Reduction of NF-kappaB Activation Mediated by PD-L1/PD-1 and Gal-9/TIM-3 Pathways.
    Zhou K; Guo S; Tong S; Sun Q; Li F; Zhang X; Qiao Y; Liang G
    Stem Cells Dev; 2018 Sep; 27(17):1191-1202. PubMed ID: 29978730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oleic acid and oleoylethanolamide decrease interferon-γ-induced expression of PD-L1 and induce apoptosis in human lung carcinoma cells.
    Yamagata K; Uzu E; Yoshigai Y; Kato C; Tagami M
    Eur J Pharmacol; 2021 Jul; 903():174116. PubMed ID: 33957086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Inflammatory factors promote the expression of PD-L1 in Tca8113].
    Lu LB; Chen J; Feng Y; Zhou CC; Zhang P
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2013 Jan; 44(1):42-5. PubMed ID: 23600206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of baricitinib in regulating programmed death 1 and ligand programmed cell death ligand 1 through JAK/STAT pathway in psoriasis.
    Deepak HB; Prince SE; Deshpande P
    Indian J Pharmacol; 2022; 54(3):183-193. PubMed ID: 35848689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Farnesyltransferase inhibitor FTI-277 inhibits PD-L1 expression on septic spleen lymphocytes and promotes spleen lymphocyte activation.
    Li W; Tu J; Liu X; Yang W
    Clin Exp Immunol; 2017 Oct; 190(1):8-18. PubMed ID: 28556912
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Licochalcone A inhibits interferon-gamma-induced programmed death-ligand 1 in lung cancer cells.
    Yuan LW; Jiang XM; Xu YL; Huang MY; Chen YC; Yu WB; Su MX; Ye ZH; Chen X; Wang Y; Lu JJ
    Phytomedicine; 2021 Jan; 80():153394. PubMed ID: 33130472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.